Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women

International Journal of Obesity

Volumn 39, Issue 5, 2015, Pages 814-819

  Stomby, A ^a   Simonyte, K ^a   Mellberg, C ^a   Ryberg, M ^a   Stimson, R H ^b   Larsson, C ^c,d   Lindahl, B ^a   Andrew, R ^b   Walker, B R ^b   Olsson, T ^a,e  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CHOLESTEROL; CORTISONE; GLUCOCORTICOID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FEMALE; GENE EXPRESSION; GLUCOCORTICOID METABOLISM; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; OBESITY; PALEOLITHIC DIET; PARAMETERS; POSTMENOPAUSE; PRIORITY JOURNAL; STEROID EXCRETION; STEROID URINE LEVEL; SUBCUTANEOUS FAT; TISSUE SPECIFICITY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADIPOSE TISSUE; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; METABOLISM; MIDDLE AGED; OVERWEIGHT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; WEIGHT LOSS PROGRAM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; BODY MASS INDEX; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; MIDDLE AGED; OVERWEIGHT; POSTMENOPAUSE; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84928924061     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.188     Document Type: Article

References (38)

1. Chanson P, Salenave S. Metabolic syndrome in Cushing's syndrome. Neuroendocrinology 2010; 92: 96-101.
2. Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab 2010; 95: 4415-4423.
3. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson MC, Toffolo G et al. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab 2005; 90: 3919-3926.
4. Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes 2009; 58: 46-53.
5. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 1998; 83: 1325-1335.
6. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
7. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 betahydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004; 53: 931-938.
8. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone D. E, Johnson O et al. Tissuespecific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421.
9. Stimson RH, Andrew R, McAvoy NC, Tripathi D, Hayes PC, Walker BR. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Diabetes 2011; 60: 720-725.
10. Lottenberg SA, Giannella-Neto D, Derendorf H, Rocha M, Bosco A, Carvalho SV et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity. Int J Clin Pharmacol Ther 1998; 36: 501-505.
11. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998; 83: 1806-1809.
12. Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes 2008; 57: 2652-2660.
13. Upreti R, Hughes KA, Livingstone D. E, Gray CD, Minns FC, Macfarlane DP et al. 5alpha-Reductase type 1 modulates insulin sensitivity in men. J Clin Endocrinol Metab 2014; 99: 1397-1406.
14. Dowman JK, Hopkins LJ, Reynolds GM, Armstrong MJ, Nasiri M, Nikolaou N et al. Loss of 5alpha-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. Endocrinology 2013; 154: 4536-4547.
15. Johnstone AM, Faber P, Andrew R, Gibney ER, Elia M, Lobley G et al. Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. Eur J Endocrinol 2004; 150: 185-194.
16. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab 2004; 89: 2711-2716.
17. Tomlinson JW, Finney J, Hughes BA, Hughes SV, Stewart PM. Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss. Diabetes 2008; 57: 1536-1543.
18. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004; 12: 9-17.
19. Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD. Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 2009; 296: E351-E357.
20. Simonyte K, Olsson T, Naslund I, Angelhed JE, Lonn L, Mattsson C et al. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue. J Clin Endocrinol Metab 2010; 95: 3527-3531.
21. Stimson RH, Mohd-Shukri NA, Bolton JL, Andrew R, Reynolds RM, Walker BR. The post-prandial rise in plasma cortisol in men is mediated by macronutrientspecific stimulation of adrenal and extra-adrenal cortisol production. J Clin Endocrinol Metab 2014; 99: 160-168.
22. Stimson RH, Johnstone AM, Homer NZ, Wake DJ, Morton NM, Andrew R et al. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. J Clin Endocrinol Metab 2007; 92: 4480-4484.
23. Lindeberg S. Food and Western Disease: Health and Nutrition from An Evolutionary Perspective. Wiley Blackwell: Chichester, West Sussex, UK, 2010.
24. Ryberg M, Sandberg S, Mellberg C, Stegle O, Lindahl B, Larsson C et al. A palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women. J Intern Med 2013; 274: 67-76.
25. Lindeberg S, Jonsson T, Granfeldt Y, Borgstrand E, Soffman J, Sjostrom K et al. A palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 2007; 50: 1795-1807.
26. Becker W, Lyhne N, Pedersen AN, Aro A, Fogelholm M, Phórsdottir JA et al. Nordic Nutrition Recommendations 2004-integrating nutrition and physical activity. Scand J Nutr 2004; 48: 178-187.
27. Mellberg C, Sandberg S, Ryberg M, Eriksson M, Brage S, Larsson C et al. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial. Eur J Clin Nutr 2014; 68: 350-357.
28. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 betahydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) 1997; 47: 231-236.
29. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. 11Betahydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiationdependent and hormonally regulated. J Steroid Biochem Mol Biol 1998; 64: 251-260.
30. Wake DJ, Homer NZ, Andrew R, Walker BR. Acute in vivo regulation of 11betahydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab 2006; 91: 4682-4688.
31. Sandeep TC, Andrew R, Homer NZ, Andrews RC, Smith K, Walker BR. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 2005; 54: 872-879.
32. Nixon M, Wake DJ, Livingstone D. E, Stimson RH, Esteves CL, Seckl JR et al. Salicylate downregulates 11beta-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization. Diabetes 2012; 61: 790-796.
33. Livingstone D. E, McInnes KJ, Walker BR, Andrew R. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res 2005; 13: 1523-1526.
34. Phillipou G. Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome. Clin Endocrinol (Oxf) 1982; 16: 433-439.
35. Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M et al. Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes 2009; 58: 39-45.
36. Basu R, Edgerton DS, Singh RJ, Cherrington A, Rizza RA. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity. Diabetes 2006; 55: 3013-3019.
37. Koska J, de Courten B, Wake DJ, Nair S, Walker BR, Bunt JC et al. 11betahydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance. Obesity (Silver Spring) 2006; 14: 1515-1522.
38. Hughes KA, Manolopoulos KN, Iqbal J, Cruden NL, Stimson RH, Reynolds RM et al. Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes 2012; 61: 1357-1364.